Condensed Consolidated Statements of Stockholders' Equity - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Accumulated Other Comprehensive Income (loss)	Accumulated Deficit
Balance at the beginning of the period (in shares) at Dec. 31, 2023		520,343,000
Balance at the beginning of the period at Dec. 31, 2023	$ 1,243,395	$ 52	$ 2,067,776	$ 762	$ (825,195)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of options (in shares)		98,000
Issuance of common stock upon exercise of options	49		49
Issuance of common stock net settlement of restricted stock units (in shares)		2,806,000
Issuance of common stock upon net settlement of restricted stock units	(10,917)		(10,917)
Vesting of common stock warrants	2,100		2,100
Share-based compensation	33,393		33,393
Executive chairman long-term performance award	13,121		13,121
Repurchase and retirement of common stock, including excise tax (in shares)		(5,238,000)
Repurchase and retirement of common stock, including excise tax	(32,830)		(32,830)
Change in accumulated other comprehensive income (loss)	(1,586)			(1,586)
Net loss	(36,060)				(36,060)
Balance at the end of the period (in shares) at Mar. 31, 2024		518,009,000
Balance at the end of the period at Mar. 31, 2024	1,210,665	$ 52	2,072,692	(824)	(861,255)
Balance at the beginning of the period (in shares) at Dec. 31, 2024		504,296,000
Balance at the beginning of the period at Dec. 31, 2024	1,085,018	$ 50	1,883,190	(314)	(797,908)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of options (in shares)		380,000
Issuance of common stock upon exercise of options	1,444		1,444
Issuance of common stock net settlement of restricted stock units (in shares)		2,527,000
Issuance of common stock upon net settlement of restricted stock units	(7,101)		(7,101)
Share-based compensation	28,437		28,437
Repurchase and retirement of common stock, including excise tax (in shares)		(26,225,000)
Repurchase and retirement of common stock, including excise tax	(112,316)	$ (2)	(112,314)
Change in accumulated other comprehensive income (loss)	38			38
Net loss	(8,260)				(8,260)
Balance at the end of the period (in shares) at Mar. 31, 2025		480,978,000
Balance at the end of the period at Mar. 31, 2025	$ 987,260	$ 48	$ 1,793,656	$ (276)	$ (806,168)